After 2 years, Sanofi’s drug ingredients spinoff takes flight
After 2 years, Sanofi’s drug ingredients spinoff takes flight fkansteiner [...]
After 2 years, Sanofi’s drug ingredients spinoff takes flight fkansteiner [...]
AstraZeneca, GSK’s cancer rival Clovis quietly unveils crippling FDA delay [...]
Back where it started: FDA restricts use of J&J’s COVID-19 [...]
Vertex, riding high on Trikafta, isn’t just a rare disease [...]
Fierce Pharma Asia—Enhertu’s breast cancer nod; Biogen, Eisai’s next play; [...]
Dupixent retakes TV ad spending crown but overall outlay for [...]
‘Who wants to make money?’ Court documents outline wild fraud [...]
Novartis halts US production of radioligand cancer therapies, citing potential [...]
Intercept sells Ocaliva rights outside the US after NASH development [...]
FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if [...]